Skip to main content

Table 1 Clinicopathological characteristics according to preoperative NLRs

From: Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer

Group   Patients low NLRs intermediate NLRs High NLRs P-value
    (< 1.5: n = 99) (1.5–3.5: n = 245) (≥3.5: n = 38)  
Age (years) < 75 289 78 182 29 0.675
≥75 93 21 63 9  
Sex Male 232 57 154 21 0.509
Female 150 42 91 17  
BMI (Kg/m2)    22.3 ± 3.0 22.3 ± 3.2 21.0 ± 3.0 0.049
Smoking History Yes 240 61 156 23 0.895
No 142 38 89 15  
PS 0–1 355 94 224 37 0.273
2 27 5 21 1  
Predicted post PFTsa ≥40 355 95 227 33 0.184
< 40 27 4 18 5  
Histology Ad 264 79 166 19 0.003
Others 118 20 79 19  
Differentiation Well 125 37 78 10 0.412
Mod/poor 257 62 167 28  
p-stage IA 212 62 131 19 0.233
IB 170 37 114 19  
Child-Pugh Score 5 342 90 220 32 0.539
≥6 40 9 25 6  
eGFR (ml/min/1.73m2) ≥60 301 85 189 27 0.094
  < 60 81 14 56 11  
Albumin (g/dl)    4.1 ± 0.29 4.1 ± 0.35 4.1 ± 0.38 0.798
CRP (mg/dl)    0.14 ± 0.39 0.22 ± 0.43 0.87 ± 2.18 <0.001
  1. aPredicted postoperative values of FEV1.0 or DLCO less than 40% are defined as high-risk results of pulmonary function tests
  2. Ad adenocarcinoma, BMI body mass index, PFT pulmonary function test, PS performance status, p-stage pathological stage